MedDataX Logo

Hemogram Parameter Changes With Sepsis Filter

NCT ID: NCT06948630

Last Updated: 2025-04-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

92 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-01-01

Study Completion Date

2024-02-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Hemodiafiltration is initiated in hemodynamically unstable patients in intensive care units. In some patients, additional devices called cytokine filters or sepsis filters are added to remove inflammatory cytokines. Data obtained from hemograms, such as platelet lymphocytosis ratio, are used in the diagnosis or prognosis of many diseases. This study focuses on the change in hemogram rates in patients who received hemofiltration and sepsis filters.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Can Gdf-15 Level Predict Progression to Multiple Organ Failure in Patients With Septic Shock

NCT06808100

Sepsis Septic Shock Multi Organ Failure
ENROLLING_BY_INVITATION

Evaluation of Candidate Biomarkers to Predict Disease Severity and Acute Kidney Injury in Sepsis Patients

NCT05310812

Sepsis Septic Shock Acute Kidney Injury
COMPLETED

Effects of Neutrophil/Lymphocyte, Platelet/Lymphocyte, CRP/Albumin and Lactate on Mortality in Trauma Patients Admitted to Intensive Care

NCT06667310

Intensive Care
COMPLETED

Investigation of The Prevalence of Sepsis in Adults in Multicenter Intensive Care Unıts in Turkey

NCT03179189

Sepsis
UNKNOWN

Comparative Effectiveness of Oxiris Hemofilters Versus Conventional Hemofilters in Septic Patients

NCT06735365

Sepsis - to Reduce Mortality in the Intensive Care Unit Hemodiafiltration Cytokine
COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Platelet Abnormality Renal Failure Immune System Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Data of patients who were monitored in the Intensive Care between January 2020 and December 2022 and who were applied sepsis filters

Exclusion Criteria

* -Patients who underwent hemodiafiltration with sepsis filter but could not be followed for 72 hours (death, etc.)
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Samsun University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Erkan Bayram

Role: STUDY_CHAIR

Istınye university faculity of Medicine

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Istinye University

Istanbul, , Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

References

Explore related publications, articles, or registry entries linked to this study.

Nassiri AA, Schneider A, Hakemi MS, Sabaghian T, Ahmadi Koomleh A, Miri MM, Entezarmahdi K, Yousefzad T, Kashani K. Scientia et Cura: Illuminating the Dark Side of CRRT for Optimal Patient Benefits. Iran J Kidney Dis. 2025 Feb 25;19(1):50-58.

Reference Type BACKGROUND
PMID: 40056440 (View on PubMed)

Wu D, Qin H. Diagnostic and prognostic values of immunocyte ratios in patients with sepsis in the intensive care unit. J Infect Dev Ctries. 2023 Oct 31;17(10):1362-1372. doi: 10.3855/jidc.17907.

Reference Type RESULT
PMID: 37956370 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Istinye University

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Blood Indices of Systemic Inflammation in Critically Ill Patients With Abdominal Sepsis
NCT06095830 NOT_YET_RECRUITING
Indicators of Inflammation and Coagulation in Sepsis
NCT01128283 COMPLETED
Predictive Value of the Uric Acid/Albumin Ratio and Lactate in Sepsis Patients
NCT07332715 NOT_YET_RECRUITING
Prognostic Value of the CALLY Index in Patients With Sepsis
NCT07285499 COMPLETED
Immune Activation, Hypoxia and Vasoreaction in Sepsis of Pulmonary Versus Abdominal Origin
NCT01530932 COMPLETED
Evaluation of the Clinical Relationship Between Procalcitonin Level and Bacteremia Agent in Intensive Care Unit Patients
NCT06958354 COMPLETED
Urinary Actin, as a Potential Marker of Sepsis-related Acute Kidney Injury
NCT04968262 COMPLETED
Kidney Response to Sepsis Affects Angiogenic Balance and Likelihood of CCI and PICS
NCT02276066 COMPLETED NA
Epidemiology and Determinants of Outcomes of Hospital Acquired Blood Stream Infections in the Intensive Care in Turkey
NCT04304456 UNKNOWN
Thromboembolic Complications in COVID-19 Patients in Intensive Care Unit
NCT06037707 COMPLETED
The Prognostic Role of Red Blood Cell Distribution (RDW) in Severe COVID-19 Patients
NCT07244731 COMPLETED
Mechanisms of Precise Immune Cell Phenotyping and Prognostic Prediction in Severe Infection
NCT07332793 NOT_YET_RECRUITING
Can Shock Indices Be Prognostic Indicators in Sepsis/Septic Shock?
NCT06415006 COMPLETED
Urinary Heparanase Activity as a Predictor of Acute Kidney Injury in Critically Ill Adults
NCT01900275 COMPLETED
System-level Monitoring of Immune Activation Concerning Susceptibility to Sepsis in Trauma Patients
NCT01472952 WITHDRAWN
Validation of a Urinary Biomarker as Diagnostic Tool for AKI in Sepsis
NCT01981993 COMPLETED
Effect of Albumin Replacement on Oxygen Delivery in Sepsis Patients
NCT06556914 RECRUITING
Thrombosis Risk Assessment and Clinical Presentation of Covid-19 Pneumonia
NCT04423315 COMPLETED
Effectiveness of the Cytokine Hemadsorption on Sepsis
NCT05057455 COMPLETED
Assessment of Red Cell Distribution Width's Prognostic Ability in Septic Intensive Care Unit Patients
NCT06847451 COMPLETED
Coagulation Factors, Cytokines and Tissue Injury Markers in Sepsis
NCT01012115 COMPLETED
İntensive Care Sepsis Prevelance in Turkey (INSEP-TURK)
NCT07283588 ACTIVE_NOT_RECRUITING
Diagnostic and Prognostic Biomarkers of Sepsis
NCT04767893 COMPLETED
Frequency, Predictors and Outcome of Sepsis Induced Coagulopathy in Critical Care Unit
NCT06586346 NOT_YET_RECRUITING
Neutrophil Lymphocyte Ratio as a Predictor of Outcome in Critically Traumatic Patients
NCT02749487 COMPLETED